Attovia Therapeutics, Inc. ATTO

Set alert

Price alert · ATTO

All alert types
15.05 USD -0.14 -0.92%

At close · Nov 2

15.05 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
15.05 × —
Ask
15.15 × —
14.90 Day range 16.23
12.94 52-week range 28.00
YTD
-31.28%
1 year
-31.28%
Open
15.27
Prev close
15.19
Mkt cap
687.05M
Vol
154.89K
Avg vol
432.80K
EPS
-2.74
P/E
0.00
Div yield
0.00%
More statistics
Low
14.90
High
16.23
Forward P/E
-9.30
Beta
0.00
Short ratio
0.54
Inst. own
40.86%
Dividend
0.00
Ex-div date
50-d avg
21.62
200-d avg
21.62
1y target
42.20

1D chart

Chart tools
Interval

Chart is warming up

The one-day price history for ATTO has not been loaded yet. Try again in a moment.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 42.20 +180.4% upside
Target (low)
30.00
Target (mean)
42.20
Target (high)
52.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ATTO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.50-0.50 – -0.500.000.0%00.0%1
Next quarter-0.52-0.52 – -0.520.000.0%00.0%1
Current year-3.45-3.45 – -3.450.000.0%466.67K0.0%1
Next year-2.38-2.38 – -2.38-3.45+31.0%0-100.0%2

Upgrades and downgrades

The latest rating changes

ATTO analyst upgrades and downgrades
DateFirmActionFromTo
Aug 31, 2026CitigroupInitiated—Buy
Aug 31, 2026LifeSci CapitalInitiated—Outperform
Aug 31, 2026Leerink PartnersInitiated—Outperform
Aug 31, 2026RBC CapitalInitiated—Outperform
Aug 31, 2026Morgan StanleyInitiated—Overweight